1. Amlodipine

   Case report 09 April 2022 Pages: 51 - 51

2. Amlodipine/azilsartan/sevoflurane

   Case report 09 April 2022 Pages: 52 - 52

3. Amphotericin-B liposomal/fluconazole

   Case report 09 April 2022 Pages: 53 - 53

4. Amphotericin-B-liposomal

   Case report 09 April 2022 Pages: 54 - 54

5. Amphotericin-B-liposomal

   Case report 09 April 2022 Pages: 55 - 55

6. Amphotericin-B/fluoxetine

   Case report 09 April 2022 Pages: 56 - 56

7. Anakinra/canakinumab/tocilizumab

   Case report 09 April 2022 Pages: 57 - 57

8. Anakinra/steroids

   Case report 09 April 2022 Pages: 58 - 58

9. Anakinra/tozinameran

   Case report 09 April 2022 Pages: 59 - 59

10. Anastrozole

    Case report 09 April 2022 Pages: 60 - 60

11. Anti-inflammatories

    Case report 09 April 2022 Pages: 61 - 61

12. Antibacterials

    Case report 09 April 2022 Pages: 62 - 62

13. Antibacterials

    Case report 09 April 2022 Pages: 63 - 63

14. Antibacterials/cefazolin/gentamicin

    Case report 09 April 2022 Pages: 64 - 64

15. Antibiotics/heparin

    Case report 09 April 2022 Pages: 65 - 65

16. Anticoagulants/eculizumab/elasomeran

    Case report 09 April 2022 Pages: 66 - 66

17. Anticoagulants/mycophenolate mofetil

    Case report 09 April 2022 Pages: 67 - 67

18. Antiepileptic-drugs

    Case report 09 April 2022 Pages: 68 - 68

19. Antihypertensives/phenylephrine/sodium-polystyrene-sulfonate

    Case report 09 April 2022 Pages: 69 - 69

20. Antineoplastics

    Case report 09 April 2022 Pages: 70 - 70

21. Antineoplastics

    Case report 09 April 2022 Pages: 71 - 71

22. Antineoplastics

    Case report 09 April 2022 Pages: 72 - 72

23. Antineoplastics

    Case report 09 April 2022 Pages: 73 - 73

24. Antineoplastics

    Case report 09 April 2022 Pages: 74 - 74

25. Antineoplastics

    Case report 09 April 2022 Pages: 75 - 75

26. Antineoplastics

    Case report 09 April 2022 Pages: 76 - 76

27. Antineoplastics

    Case report 09 April 2022 Pages: 77 - 77

28. Antineoplastics

    Case report 09 April 2022 Pages: 78 - 78

29. Antineoplastics/rasburicase

    Case report 09 April 2022 Pages: 79 - 79

30. Antituberculars

    Case report 09 April 2022 Pages: 80 - 81

31. Apalutamide

    Case report 09 April 2022 Pages: 81 - 81

32. Apixaban

    Case report 09 April 2022 Pages: 82 - 82

33. Apixaban

    Case report 09 April 2022 Pages: 83 - 83

34. Apixaban

    Case report 09 April 2022 Pages: 84 - 84

35. Apixaban

    Case report 09 April 2022 Pages: 85 - 85

36. Apixaban

    Case report 09 April 2022 Pages: 86 - 86

37. Apixaban/ciprofloxacin/levofloxacin

    Case report 09 April 2022 Pages: 87 - 87

38. Apixaban/dabigatran etexilate/enoxaparin sodium

    Case report 09 April 2022 Pages: 88 - 88

39. Apixaban/diltiazem interaction

    Case report 09 April 2022 Pages: 89 - 89

40. Aprotinin

    Case report 09 April 2022 Pages: 90 - 90

41. Aripiprazole/fluoxetine interaction

    Case report 09 April 2022 Pages: 91 - 91

42. Arsenic-trioxide/tretinoin

    Case report 09 April 2022 Pages: 92 - 92

43. Arsenic-trioxide/tretinoin

    Case report 09 April 2022 Pages: 93 - 93

44. Aspirin

    Case report 09 April 2022 Pages: 94 - 94

45. Aspirin

    Case report 09 April 2022 Pages: 95 - 95

46. Aspirin

    Case report 09 April 2022 Pages: 96 - 96

47. Aspirin

    Case report 09 April 2022 Pages: 97 - 97

48. Aspirin/cyclophosphamide/nonsteroidal-anti-inflammatories

    Case report 09 April 2022 Pages: 98 - 98

49. Aspirin/ticagrelor

    Case report 09 April 2022 Pages: 99 - 99

50. Aspirin/warfarin

    Case report 09 April 2022 Pages: 100 - 100